DTIL (Precision BioSciences) Days Sales Outstanding: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DTIL Precision BioSciences Inc DTIL
45 GF Score
Price $6.65
GF Value $1.31
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Precision BioSciences Days Sales Outstanding?

Precision BioSciences's average Accounts Receivable for the three months ended in Jun. 2026 was $4.00 Mil. Precision BioSciences's Revenue for the three months ended in Jun. 2026 was $0.00 Mil.

The historical rank and industry rank for Precision BioSciences's Days Sales Outstanding or its related term are showing as below:

DTIL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.44   Med: 10.5   Max: 82.4
Current: 10.82

During the past 10 years, Precision BioSciences's highest Days Sales Outstanding was 82.40. The lowest was 2.44. And the median was 10.50.

DTIL's Days Sales Outstanding is ranked better than
94.29% of 840 companies
in the Biotechnology industry
Industry Median: 69.01 vs DTIL: 10.82

Precision BioSciences's Days Sales Outstanding declined from Jun. 2025 (20.28) to Jun. 2026 ().

Precision BioSciences  (NAS:DTIL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Precision BioSciences Days Sales Outstanding Related Terms

Precision BioSciences Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences Days Sales Outstanding Chart

Precision BioSciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.57 8.78 6.07 6.91 18.09

Precision BioSciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.28 28.08 0.01 33.68 -

DTIL vs NBP, PEPG, CHRS: Days Sales Outstanding Comparison

For the Biotechnology subindustry, Precision BioSciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precision BioSciences Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's Days Sales Outstanding falls into.


DTIL
45GF Score
Precision BioSciences Inc DTIL
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Precision BioSciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( (1.698 + 0) / 1 ) / 34.264*365
=1.698 / 34.264*365
=18.09

Precision BioSciences's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2026 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( (4 + 0) / 1 ) / 0*365 / 4
=4 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Precision BioSciences (DTIL) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of $6.65 is trading 407.6% above its estimated GF Value™ of $1.31. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for DTIL:

  • Days Sales Outstanding:
  • GF Value™: $1.31 vs. price of $6.65 (407.6% above fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the DTIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges PBS0:Germany
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
45GF Score

Get the complete analysis for DTIL

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.65
Price
$1.31
GF Value